Literature DB >> 32115484

[Pathogenic roles of retinal glia in glaucoma].

Youichi Shinozaki1, Schuichi Koizumi1.   

Abstract

Glaucoma, progressive optic neuropathy, is the first cause of blindness in Japan. Blindness in this disease is induced by damages or degeneration of retinal ganglion cells (RGCs), retinal neurons transmit visual information to brain. An elevated intraocular pressure (IOP) is widely recognized as one of the most important risk factors and that IOP directly damages RGCs by mechanical stress, however, accumulating evidences have shown that a majority of Japanese patients for primary open angle glaucoma shows normal level of IOP. Thus, new target for glaucoma pathology is emerged. In this issue, we introduce potential roles of glial cells for pathogenesis of glaucoma. In the CNS, reactive gliosis has been recognized in a variety of neurodegenerative diseases. Such glial activation is also found in retinae of human glaucoma patients and animal models. Importantly, glial activation precedes RGS degeneration, indicating the possibility that reactive glial cells actively contribute to pathogenesis of glaucoma. In this issue, we will focus on macroglial cells such as Muller cells and astrocytes, and discuss their roles in glaucoma.

Entities:  

Year:  2020        PMID: 32115484     DOI: 10.1254/fpj.19120

Source DB:  PubMed          Journal:  Nihon Yakurigaku Zasshi        ISSN: 0015-5691


  2 in total

1.  Statins Inhibit the Gliosis of MIO-M1, a Müller Glial Cell Line Induced by TRPV4 Activation.

Authors:  Youn Hye Jo; Go Woon Choi; Mi-Lyang Kim; Kyung Rim Sung
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

2.  Gynostemma Glycosides Protect Retinal Ganglion Cells in Rats with Chronic High Intraocular Pressure by Regulating the STAT3/JAK2 Signaling Pathway and Inhibiting Astrocyte and Microglia Activation.

Authors:  Xian-Jing Wang; Rong Hu; Qiong-Ying Huang; Qing-Hua Peng; Juan Yu
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-11       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.